Andere Kunden interessierten sich auch für
![Targeting Oncogenic Driver Mutations in Lung Cancer]( "Targeting Oncogenic Driver Mutations in Lung Cancer")
Targeting Oncogenic Driver Mutations in Lung Cancer25,99 €![Prostate Cancer Imaging and Therapy, an Issue of Pet Clinics]( "Prostate Cancer Imaging and Therapy, an Issue of Pet Clinics")
Prostate Cancer Imaging and Therapy, an Issue of Pet Clinics90,99 €![Therapeutic Targeting of RAS Mutant Cancers]( "Therapeutic Targeting of RAS Mutant Cancers")
Therapeutic Targeting of RAS Mutant Cancers25,99 €![Personalized drug screening for functional tumor profiling]( "Personalized drug screening for functional tumor profiling")
Personalized drug screening for functional tumor profiling25,99 €![Lung Cancer: A Practical Approach to Evidence-Based Clinical Evaluation and Management]( "Lung Cancer: A Practical Approach to Evidence-Based Clinical Evaluation and Management")
Lung Cancer: A Practical Approach to Evidence-Based Clinical Evaluation and Management114,99 €![Human Herpesviruses Hhv-6a, Hhv-6b and Hhv-7]( "Human Herpesviruses Hhv-6a, Hhv-6b and Hhv-7")
Human Herpesviruses Hhv-6a, Hhv-6b and Hhv-7158,99 €![Overcoming Resistance to Egfr Inhibitors in Egfr-Mutant Nsclc]( "Overcoming Resistance to Egfr Inhibitors in Egfr-Mutant Nsclc")
Overcoming Resistance to Egfr Inhibitors in Egfr-Mutant Nsclc186,99 €
This Element describes the structural biology and pathophysiology of EGFR-mutant NSCLC and describes past, current, and future treatment options in different settings. It discusses the biology and recently approved treatment for EGFR-exon 20 insertion mutation and the treatment for the uncommon mutations.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.